We present an HPLC method for the determination of amino acids in plasma. The method is based on automated precolumn derivatization of amino acids with o-phthalaldehyde, separation of the derivatives by reversed-phase chromatography, and quantification by fluorescence detection. Complete separation was achieved within 12 mm. Total analysis time, includingderivatization, chromatography, and reequilibration of the column, was 17 mm. The assay was linear from 5 to 800 mol/L for all amino acids. Recovery of amino acids added to plasma samples was 96-106%, except for tryptophan (89%). Within-run precision (CV) was 1.8-6.4%, and betweenrun precision was 2.1-7.2%. The method can be used for determining primary amino acids in plasma and cerebrospinal fluid. The simple sample preparation and short analysis time make the method particularly suitable for routine analysis of large series of samples. 
amino acids (1) (2) (3) .
The beneficial
effects of these feedings on the nutritional status of patients has stimulated clinicians and researchers to study amino acid metabolism in different disease states (4) (5) (6) 
MaterIals and Methods Chemicals
We obtained OPA and MPA from Fluka (Buchs, Switzerland Hospital and with oral informed consent of each subject. The clear supennatants were transferred to polypropylene vials and stored in a refrigerated (4#{176}C) sample rack of the autosampler.
Collection and Processing of Samples

Preparation of Reagents
The OPA-MPA reagent stock solution was prepared every 3 days. We dissolved 25 mg of OPA in 0.5 mL of methanol, after which we added 4. from the bottom of the tube and dispensing it from a height of 5 mm. After a 3-mm incubation at room temperature, 50 pi of neutralizing buffer was added; after mixing as described above, 3 L of the reaction mixture was injected. The needle of the autosampler was washed with water between all fluidtransfer steps. During chromatography of one sample, the next sample was being derivatized.
Chromatographic separation was performed at ambient temperature. Table 1 shows the composition of the eluent during analysis. Detection was performed fluorometrically by using an excitation wavelength of 230 nm and an emission cutoff filter of 389 nm. We calculated amino acid concentrations by using the peak area relative to the area of the internal standard peak.
Assay Performance
Linearity of the analysis was determined from 5 to 800 tmol/L by plotting peak response (area of the amino acid peak divided by the area of the internal standard peak) vs concentration.
At concentrations 100 mol/L, a mixture of all amino acids evaluated was used. At higher concentrations, mixtures of only five amino acids were analyzed, to ensure that the OPA-MPA reagent was present in sufficient excess for complete denivatization.
Within-run reproducibility was evaluated by replicate analysis of a standard solution (n = 33) and a plasma pool (n = 28) in a single run. Between-run reproducibility was Table 1 . HPLC gradient condltions.
Tim., mln % mobll#{149} phas. B In eluent 0.0 tested by analyzing a plasma pool stored at -70#{176}C on different days over 4 months (n = 24). Recovery was evaluated by mixing equal volumes of plasma and amino acid standard mixture or water. After mixing, the samples were deproteinized with SSA-coated tubes and analyzed immediately.
Recovery was calculated as the difference between samples containing amino acid standards and samples without the mixture,
A
expressed as a percentage of the amount of amino acid added. Inclusion of triethylanilne in mobile phase A allowed separation of aspartic acid from SSA used to deproteinize the plasma samples. The elution position of histidine and arginine relative to the other amino acids can be shifted by adjusting the ionic strength of the mobile phase buffer. Separation of 1-methyihistidine and 3-methyihistidine was optimized by varying the pH of the mobile phase buffer. After determining the optimal composition of the eluents, fine-tuning of the separation was performed by modifying the gradient shape. By using a segmented gradient (Table 1) , resolution was improved with a concurrent reduction of analysis time. There was a linear relation between peak response (ratio of areas of amino acid and internal standard) and concentration from 5 to 800 moI/L for all amino acids (correlation coefficients all >0.999). Within-run precision was determined by replicate analysis of an amino acid standard solution (n = 33) and a plasma sample (n = 28). For the standard solution the CV was 1.0-1.8%. For the plasma sample the CV was 1.8-4.9%
Results
Fig
with the exception of aspartic acid (6.4%). For quality-control purposes a plasma pool was stored at -70#{176}C in small aliquots;
this sample was analyzed in each run. Between-run CV, assessed from the results from 24 consecutive runs performed over 4 months, was <5% with the exceptions of aspartic acid (7.2%), taurine (5.8%), and tryptophan (6.1%). Accuracy of the method was evaluated by determining analytical recovery. Recovery of amino acids added to plasma (n = 12) was 96-103% for all amino acids, with the exception of tryptophan (89%) and aspartic acid (106%). Amino acid concentrations determined in plasma of 44 healthy volunteers are summarized in Table 2 .
DiscussIon
The objective of this study was to develop a fast and reliable method for the analysis of plasma amino acids. Precolumn derivatization with OPA was used because the derivatization can be easily automated. with higher OPA concentrations, we observed that some amino acid derivatives (i.e., glycine, histidine, and taurine) degraded, and some additional unidentified peaks probably representing degradation products appeared in the chromatograms. This is in accordance with reports that excess OPA accelerates degradation of isoindole derivatives (24). On-column degradation of the derivatives was minimized by using a short column in combination with a high flow rate, resulting in an analysis time of only 12 mm. To obtain sufficient resolution, we used a column containing 3-nm particles. An additional advantage of these small-diameter particles is that resolution is only marginally decreased at high flow rates, due to a more efficient mass transfer.
To obtain reliable values for plasma amino acids, we paid special attention to sample pretreatment. After collection of blood, plasma was immediately separated from blood cells by centrifugation, and plasma proteins were then precipitated by addition of SSA. In a comparison of various deproteinizing agents, Qureshi and Qureshi showed SSA to be superior to other agents (16). We used special tubes containing solid SSA to avoid errors due to sample dilution. After mixing within the tubes, the samples were quickly frozen in liquid nitrogen and then stored at -70#{176}C. In our experience, samples prepared in this way can be stored for at least 1 year without change in amino acid concentrations.
This method is characterized by high precision and reproducibifity for all amino acids evaluated. With one exception, the recoveries of amino acids added to plasma were close to 100%. The lower recovery of tryptophan (89%) probably reflects the fact that this amino acid is tightly bound to albumin (19). Plasma amino acid concentrations of healthy subjects determined by the present method ( 15-18,20,23) .
Although we are primarily interested in plasma amino acids, the method can also be applied to the determination of amino acids in cerebrospinal fluid. The method is characterized by speed of analysis and minimal manual sample handling. With proper care the column can be used for at least 500 analyses.
If the separation efficiency decreases, column performance can be restored by flushing the column with 0.2 mol/L phosphate buffer (pH 2.5).
